BR100 Increased By (0.59%)
BR30 Increased By (1.07%)
KSE100 Increased By (0.46%)
KSE30 Increased By (0.52%)
AGHA 6.61 No Change ▼ 0.00 (0%)
BECO 4.24 Increased By ▲ 0.07 (1.68%)
BML 61.45 Increased By ▲ 2.76 (4.7%)
BOP 28.81 Increased By ▲ 0.23 (0.8%)
CNERGY 12.80 Increased By ▲ 0.09 (0.71%)
CSIL 5.56 Increased By ▲ 0.09 (1.65%)
FCCL 51.99 Increased By ▲ 0.52 (1.01%)
FFL 14.02 Increased By ▲ 0.01 (0.07%)
FNEL 1.12 No Change ▼ 0.00 (0%)
KEL 5.91 Decreased By ▼ -0.03 (-0.51%)
KOSM 5.44 Decreased By ▼ -0.03 (-0.55%)
LOTCHEM 25.82 Decreased By ▼ -0.49 (-1.86%)
MLCF 90.45 Increased By ▲ 0.64 (0.71%)
NBP 159.27 Increased By ▲ 0.47 (0.3%)
NCPL 49.08 Increased By ▲ 0.82 (1.7%)
NPL 52.43 Decreased By ▼ -0.08 (-0.15%)
OGDC 302.25 Increased By ▲ 2.51 (0.84%)
PACE 9.86 Increased By ▲ 0.16 (1.65%)
PAEL 33.73 Increased By ▲ 0.14 (0.42%)
PIBTL 13.71 Decreased By ▼ -0.01 (-0.07%)
PPL 219.25 Increased By ▲ 1.78 (0.82%)
PRL 103.76 Increased By ▲ 4.57 (4.61%)
PTC 55.06 Increased By ▲ 3.90 (7.62%)
SSGC 23.02 Increased By ▲ 0.40 (1.77%)
TBL 9.77 Increased By ▲ 0.42 (4.49%)
TELE 7.23 Increased By ▲ 0.18 (2.55%)
TPL 20.67 Decreased By ▼ -0.11 (-0.53%)
TPLP 11.87 Increased By ▲ 0.05 (0.42%)
TREET 23.60 Decreased By ▼ -0.39 (-1.63%)
TRG 55.47 Decreased By ▼ -1.08 (-1.91%)
World

Zaghari-Ratcliffe's new Iran trial 'unacceptable': UK

  • "She must be allowed to return to her family in the UK without delay. We continue to do all we can to support her," he added.
Published Updated
By

LONDON: New charges of "propaganda against the system" made by Iran against British-Iranian national Nazanin Zaghari-Ratcliffe, a week after she finished serving a five-year sentence, are "unacceptable", Britain said Sunday.

"It is unacceptable that Iran has chosen to continue a second wholly arbitrary case against Nazanin Zaghari-Ratcliffe," Foreign Secretary Dominic Raab wrote on Twitter.

"She must be allowed to return to her family in the UK without delay. We continue to do all we can to support her," he added.

Comments

Comments are closed for this article.